Franklin Resources, Inc Form 8.3 - Pfizer Inc. (5115G)

TIDMPFZ

RNS Number : 5115G

Franklin Resources, Inc

20 November 2015

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1967,

TAKEOVER RULES, 2007 (AS AMENDED)

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES

REPRESENTING 1% OR MORE

   1.         KEY INFORMATION 
 
 Name of person dealing                  Franklin Resources, Inc. 
  (Note 1) 
--------------------------------------  ------------------------- 
 Company dealt in                        Pfizer Inc. 
--------------------------------------  ------------------------- 
            Class of relevant security   Ordinary Shares 
             to which the dealings 
             being disclosed relate 
             (Note 2) 
--------------------------------------  ------------------------- 
            Date of dealing              19 November 2015 
--------------------------------------  ------------------------- 
 
   2.         INTERESTS AND SHORT POSITIONS 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 
                                          Long            Short 
---------------------------------  -----------------  ------------- 
                                    Number (%)         Number (%) 
---------------------------------  -----------------  ------------- 
      (1) Relevant securities       65,133,825 1.06% 
---------------------------------  -----------------  ------------- 
      (2) Derivatives (other 
       than options) 
---------------------------------  -----------------  ------------- 
      (3) Options and agreements 
       to purchase/sell                                3,000 0.00% 
---------------------------------  -----------------  ------------- 
 Total                              65,133,825 1.06%    3,000 0.00% 
---------------------------------  -----------------  ------------- 
 

Please note: the total share position, since the previous disclosure, includes the transfer out of 290 ordinary shares of discretionary holdings.

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 
   Class of relevant security:        Long        Short 
--------------------------------  -----------  ----------- 
                                   Number (%)   Number (%) 
--------------------------------  -----------  ----------- 
      (1) Relevant securities 
--------------------------------  -----------  ----------- 
      (2) Derivatives (other 
       than options) 
--------------------------------  -----------  ----------- 
      (3) Options and agreements 
       to purchase/sell 
--------------------------------  -----------  ----------- 
 Total 
--------------------------------  -----------  ----------- 
 
   3.         DEALINGS (Note 4) 
   (a)        Purchases and sales 
 
 Purchase/sale   Number of relevant   Price per unit (Note 
                  securities           5) 
--------------  -------------------  --------------------- 
     Sale              14,052             32.1954 USD 
--------------  -------------------  --------------------- 
 
   (b)        Derivatives transactions (other than options transactions) 
 
 Product name,   Nature of      Number of relevant   Price per unit 
  e.g. CFD        transaction    securities (Note     (Note 5) 
                  (Note 6)       7) 
--------------  -------------  -------------------  --------------- 
 
 
   (c)        Options transactions in respect of existing relevant securities 
   (i)         Writing, selling, purchasing or varying 
 
 Product      Writing,       Number of     Exercise   Type,        Expiry   Option 
  name,        selling,       securities    price      e.g.         date     money 
  e.g. call    purchasing,    to which                 American,             paid/received 
  option       varying        the option               European              per unit 
               etc.           relates                  etc.                  (Note 5) 
                              (Note 7) 
-----------  -------------  ------------  ---------  -----------  -------  --------------- 
 
 
   (ii)        Exercising 
 
 Product name, e.g.   Number of securities   Exercise price per 
  call option                                 unit (Note 5) 
-------------------  ---------------------  ------------------- 
 
 
   (d)        Other dealings (including transactions in respect of new securities) (Note 4) 
 
 Nature of transaction   Details   Price per unit (if 
  (Note 8)                          applicable) (Note 
                                    5) 
----------------------  --------  ------------------- 
 
 
   4.         OTHER INFORMATION 

Agreements, arrangements or understandings relating to options or derivatives

 
 Full details of any agreement, arrangement or understanding 
  between the person disclosing and any other person relating 
  to the voting rights of any relevant securities under 
  any option referred to on this form or relating to the 
  voting rights or future acquisition or disposal of any 
  relevant securities to which any derivative referred 
  to on this form is referenced. If none, this should 
  be stated. 
------------------------------------------------------------- 
 None stated. 
------------------------------------------------------------- 
 
   Is a Supplemental Form 8 attached? (Note 9)                                                 YES 

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

 
  Product       Written,       Number of     Exercise   Type, e.g.  Expiry date 
    name,      or purchased     relevant       price     American, 
  e.g. call                    securities     (Note 2)   European 
   option                       to which                   etc. 
                               the option 
                              or derivative 
                                 relates 
============  =============  ==============  =========  ==========  =========== 
 Call Option   Written                3,000  36.00 USD   American   20 Nov 2015 
============  =============  ==============  =========  ==========  =========== 
 
 
 
 
            Date of disclosure                 20 November 2015 
--------------------------------------------  ------------------------------------ 
            Contact name                       Cathy Johnson 
--------------------------------------------  ------------------------------------ 
            Telephone number                   [phone] 
                                                [e-mail] 
--------------------------------------------  ------------------------------------ 
 If a connected EFM, name of offeree/offeror   N/A 
  with which connected 
--------------------------------------------  ------------------------------------ 
            If a connected EFM, state nature   N/A 
             of connection (Note 10) 
--------------------------------------------  ------------------------------------ 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

ISEPKKDQPBDDKDB

(END) Dow Jones Newswires

November 20, 2015 10:43 ET (15:43 GMT)